{"disease":{"id":"colon-cancer-stage-ii-amp-amp-iii","name":"colon cancer stage ii amp amp iii"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT07012538","title":"RASi for Preventing Postoperative Recurrence of Stage II/III Colon Cancer","phase":"","overall_status":"COMPLETED","enrollment_count":2640,"lead_sponsor_name":"Fudan University","has_results":false},{"nct_id":"NCT06609551","title":"ctDNA-guided Selection of Adjuvant Chemotherapy Regimens for Elderly Colon Cancer Patients After Surgery: A Single-center, Randomized, Controlled Study","phase":"PHASE3","overall_status":"RECRUITING","enrollment_count":312,"lead_sponsor_name":"Zhejiang Cancer Hospital","has_results":false},{"nct_id":"NCT06890624","title":"MFOLFOXIRI Plus PD-1 Inhibitor Vs MFOLFOX6 As Neoadjuvant Therapy for Locally Advanced Colon Cancer","phase":"PHASE2","overall_status":"NOT_YET_RECRUITING","enrollment_count":138,"lead_sponsor_name":"Sun Yat-sen University","has_results":false}],"total":3},"guidelines":[],"source":"Drug Landscape verified database"}